K090145 is an FDA 510(k) clearance for the SURECALL EMG LABOR MONITOR. Classified as Uterine Electromyographic Monitor (product code OSP), Class II - Special Controls.
Submitted by Reproductive Research Technologies, LP (Houston, US). The FDA issued a Cleared decision on January 25, 2011 after a review of 734 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.2720 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.
NCT01282710
Completed
Observational
Industry-sponsored
Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant Women
Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement in Pregnant Women
| Condition studied |
Pregnancy - Labor Monitoring |
| Eligibility |
Female only
· 15 Years+
|
| Principal investigator |
Timothy B Waterhouse, MD |
| Sponsor |
Reproductive Research Technologies, LP
(industry)
|
Started 2008-08-01
→
Primary completion 2008-12-01
Primary outcome
Comparison of SureCALL® and TOCO Detection of Contraction Events, as Compared to the IUPC
View full study on ClinicalTrials.gov